Volume 63, Pages S115-S118 (June 2003)

Slides:



Advertisements
Similar presentations
Parathyroidectomy: Whom and when?
Advertisements

Volume 56, Pages S238-S241 (July 1999)
Volume 65, Issue 2, Pages (February 2004)
Beta blockers in the management of chronic kidney disease
Volume 70, Issue 8, Pages (October 2006)
S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan  Kidney International 
Anemia management in chronic kidney disease
C-reactive protein and dialysis access
Parathyroidectomy: Whom and when?
Reassessment of the care of the patient with chronic kidney disease
Progression of renal failure and hypertensive nephrosclerosis
Volume 63, Pages S88-S90 (June 2003)
C-reactive protein and dialysis access
Volume 75, Issue 11, Pages (June 2009)
Volume 68, Issue 4, Pages (October 2005)
Volume 76, Pages S50-S99 (August 2009)
George A. Kaysen, Burl R. Don
Prediction of hypertension in chronic hemodialysis patients
Volume 66, Pages S13-S17 (September 2004)
A new era in phosphate binder therapy: What are the options?
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan  Kidney International 
Nephrology Crosswords: Hemodialysis
Volume 87, Issue 2, Pages (February 2015)
Volume 71, Issue 11, Pages (June 2007)
Edmund G. Lowrie  Kidney International 
Prevention of renal failure: The Malaysian experience
Study of Heart and Renal Protection (SHARP)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Charles R. Nolan, Wajeh Y. Qunibi  Kidney International 
Blood pressure targets in hemodialysis patients
Volume 67, Pages S63-S68 (January 2005)
Volume 75, Issue 11, Pages (June 2009)
New insights in uremic toxins
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Nephrology in Latin America, with special emphasis on Brazil
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease  Yoshiki Nishizawa,
Simvastatin in nephrotic syndrome
Nephrology Crossword: Glomerulonephritis
Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.
Volume 67, Issue 5, Pages (May 2005)
Daily nocturnal home hemodialysis
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Current status of maintenance hemodialysis in Beijing, China
Organ transplantation goes to the movies
Volume 56, Pages S71-S74 (November 1999)
Volume 55, Pages S3-S16 (June 1999)
Volume 56, Pages S238-S241 (July 1999)
Volume 80, Issue 10, Pages (November 2011)
Volume 70, Issue 7, Pages (October 2006)
Charles A. Herzog  Kidney International 
Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa 
Volume 70, Issue 5, Pages (September 2006)
Volume 56, Issue 1, Pages (July 1999)
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Volume 55, Pages S41-S46 (June 1999)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Volume 54, Pages S112-S119 (December 1998)
Morphology of the heart and arteries in renal failure
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Characteristics of sudden death in hemodialysis patients
Presentation transcript:

Volume 63, Pages S115-S118 (June 2003) Heart valve calcification and calcium x phosphorus product in hemodialysis patients: Analysis of optimum values for its prevention  Margarita Rufino, Sagrario García, Alejandro Jiménez, Alejandra Alvarez, Rosa Miquel, Patricia Delgado, Domingo Marrero, Armando Torres, Daniel Hernández, Victor Lorenzo  Kidney International  Volume 63, Pages S115-S118 (June 2003) DOI: 10.1046/j.1523-1755.63.s85.27.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 ROC curve for Ca x P as predictor of VC presence. The optimal predictor cut-off value (*) was that of the highest sensitivity together with the lowest number of false positives. This value corresponds to Ca x P = 43.24mg2/dL2. Kidney International 2003 63, S115-S118DOI: (10.1046/j.1523-1755.63.s85.27.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.